2014
DOI: 10.1590/s1984-82502014000300013
|View full text |Cite
|
Sign up to set email alerts
|

Quick and simple LC-MS/MS method for the determination of simvastatin in human plasma: application to pharmacokinetics and bioequivalence studies

Abstract: A simple, rapid, and sensitive method based on liquid chromatography-tandem mass spectrometry for the quantitative determination of simvastatin in human plasma was developed and validated. After a simple extraction with methyl tert-butyl ether, the analyte and internal standard (lovastatin) were analyzed using reverse-phase liquid chromatography, on a Kinetex C 18 column (100 × 4.6 mm, 2.6 μm) using acetonitrile: ammonium acetate (2 mM + 0.025 % formic acid) (70: 30, v/v) as a mobile phase in a run time of 3.5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 8 publications
0
0
0
Order By: Relevance
“…Furthermore, t 1/2 and t max were comparable in 20 Chinese healthy volunteers receiving 20 mg of simvastatin 44 . Similar simvastatin t max was also found in a study in Brazilian volunteers receiving 40 mg of simvastatin 45 …”
Section: Resultssupporting
confidence: 84%
See 1 more Smart Citation
“…Furthermore, t 1/2 and t max were comparable in 20 Chinese healthy volunteers receiving 20 mg of simvastatin 44 . Similar simvastatin t max was also found in a study in Brazilian volunteers receiving 40 mg of simvastatin 45 …”
Section: Resultssupporting
confidence: 84%
“…44 Similar simvastatin t max was also found in a study in Brazilian volunteers receiving 40 mg of simvastatin. 45 The mean plasma concentration of conjugated and total ezetimibe, as well as simvastatin and simvastatin β-hydroxy acid against the time profiles for the 3-period administrations of the reference and test formulations are represented in Figure 1. Simvastatin and its metabolite were eliminated abruptly during the first 48 hours, while ezetimibe with the longer t 1/2 was gradually eliminated throughout the 72 hours.…”
Section: Resultsmentioning
confidence: 99%